Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Combination of immortalization and inducible death strategies to generate a human mesenchymal stromal cell line with controlled survival
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 2358877
Author(s) Bourgine, P.; LeMagnen, C.; Pigeot, S.; Geurts, J.; Scherberich, A.; Martin, I.
Author(s) at UniBasel Geurts, Jeroen
Scherberich, Arnaud
Year 2014
Title Combination of immortalization and inducible death strategies to generate a human mesenchymal stromal cell line with controlled survival
Journal Stem Cell Research
Volume 12
Number 2
Pages / Article-Number 584-98
Abstract The hTERT-immortalization of human bone marrow-derived Mesenchymal Stromal Cells (hMSCs) was proposed to address availability/standardization issues for experimental or clinical studies, but raised concerns due to possible uncontrolled growth or malignant cell transformation. Here we report a method to generate a hMSCs line with controlled survival, through the implementation of a pre-established suicide system (inducible caspase 9, iCasp9) in hTERT-transduced hMSCs. Primary hMSCs were successfully immortalized (< 280PD) and further transduced with the iCasp9 device. A clone was selected and shown to maintain typical properties of primary hMSCs, including phenotype, differentiation and immunomodulation capacities. The successive transductions did not induce tumorigenic transformation, as assessed by analysis of cell cycle regulators and in vivo luciferase-based cell tracking. Cells could be efficiently induced toward apoptosis (< 95%) both in vitro and in vivo. By combining the opposite concepts of `induced-life’ and `inducible-death’, we generated a hMSCs line with defined properties and allowing for temporally controlled survival. The cell line represents a relevant tool for medical discovery in regenerative medicine and a potential means to address availability, standardization and safety requirements in cell & gene therapy. The concept of a hTERT-iCasp9 combination, here explored in the context of hMSCs, could be extended to other types of progenitor/stem cells.
Publisher Elsevier
ISSN/ISBN 1873-5061 ; 1876-7753
edoc-URL http://edoc.unibas.ch/dok/A6223362
Full Text on edoc No
Digital Object Identifier DOI 10.1016/j.scr.2013.12.006
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/24561906
ISI-Number WOS:000342286600022
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.378 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
04/05/2024